These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 31206748)

  • 1. Pharmacoepidemiology: Using randomised control trials and observational studies in clinical decision-making.
    Caparrotta TM; Dear JW; Colhoun HM; Webb DJ
    Br J Clin Pharmacol; 2019 Sep; 85(9):1907-1924. PubMed ID: 31206748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The limitations of observation studies for decision making regarding drugs efficacy and safety.
    Gueyffier F; Cucherat M
    Therapie; 2019 Apr; 74(2):181-185. PubMed ID: 30514576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of health care databases for pharmacoepidemiology.
    Takahashi Y; Nishida Y; Asai S
    Eur J Clin Pharmacol; 2012 Feb; 68(2):123-9. PubMed ID: 21808989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making.
    Sarri G; Patorno E; Yuan H; Guo JJ; Bennett D; Wen X; Zullo AR; Largent J; Panaccio M; Gokhale M; Moga DC; Ali MS; Debray TPA
    BMJ Evid Based Med; 2022 Apr; 27(2):109-119. PubMed ID: 33298465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials.
    King M; Nazareth I; Lampe F; Bower P; Chandler M; Morou M; Sibbald B; Lai R
    Health Technol Assess; 2005 Sep; 9(35):1-186, iii-iv. PubMed ID: 16153352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication safety research by observational study design.
    Lao KS; Chui CS; Man KK; Lau WC; Chan EW; Wong IC
    Int J Clin Pharm; 2016 Jun; 38(3):676-84. PubMed ID: 27003827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informing Healthcare Decisions with Observational Research Assessing Causal Effect. An Official American Thoracic Society Research Statement.
    Gershon AS; Lindenauer PK; Wilson KC; Rose L; Walkey AJ; Sadatsafavi M; Anstrom KJ; Au DH; Bender BG; Brookhart MA; Dweik RA; Han MK; Joo MJ; Lavergne V; Mehta AB; Miravitlles M; Mularski RA; Roche N; Oren E; Riekert KA; Schoenberg NC; Stukel TA; Weiss CH; Wunsch H; Africk JJ; Krishnan JA
    Am J Respir Crit Care Med; 2021 Jan; 203(1):14-23. PubMed ID: 33385220
    [No Abstract]   [Full Text] [Related]  

  • 9. Study designs in paediatric pharmacoepidemiology.
    Verhamme K; Sturkenboom M
    Eur J Clin Pharmacol; 2011 May; 67 Suppl 1():67-74. PubMed ID: 21107830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creating and synthesizing evidence with decision makers in mind: integrating evidence from clinical trials and other study designs.
    Atkins D
    Med Care; 2007 Oct; 45(10 Supl 2):S16-22. PubMed ID: 17909376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of guidelines for good practice in decision-analytic modelling in health technology assessment.
    Philips Z; Ginnelly L; Sculpher M; Claxton K; Golder S; Riemsma R; Woolacoot N; Glanville J
    Health Technol Assess; 2004 Sep; 8(36):iii-iv, ix-xi, 1-158. PubMed ID: 15361314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies.
    MacLehose RR; Reeves BC; Harvey IM; Sheldon TA; Russell IT; Black AM
    Health Technol Assess; 2000; 4(34):1-154. PubMed ID: 11134917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Untapped Potential of Observational Research to Inform Clinical Decision Making: American Society of Clinical Oncology Research Statement.
    Visvanathan K; Levit LA; Raghavan D; Hudis CA; Wong S; Dueck A; Lyman GH
    J Clin Oncol; 2017 Jun; 35(16):1845-1854. PubMed ID: 28358653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Healthcare Research into Anti-VEGF Therapy: Selection and Methodological Precautions].
    Ziemssen F; Stahl A; Dimopoulos S
    Klin Monbl Augenheilkd; 2017 Dec; 234(12):1483-1492. PubMed ID: 28834972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoepidemiology research: delivering evidence about drug safety and effectiveness in mental health.
    Davis KAS; Farooq S; Hayes JF; John A; Lee W; MacCabe JH; McIntosh A; Osborn DPJ; Stewart RJ; Woelbert E
    Lancet Psychiatry; 2020 Apr; 7(4):363-370. PubMed ID: 31780306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in data monitoring and interim analysis of trials.
    Grant AM; Altman DG; Babiker AB; Campbell MK; Clemens FJ; Darbyshire JH; Elbourne DR; McLeer SK; Parmar MK; Pocock SJ; Spiegelhalter DJ; Sydes MR; Walker AE; Wallace SA;
    Health Technol Assess; 2005 Mar; 9(7):1-238, iii-iv. PubMed ID: 15763038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observational research--opportunities and limitations.
    Boyko EJ
    J Diabetes Complications; 2013; 27(6):642-8. PubMed ID: 24055326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of fibrin sealant during non-emergency surgery: a systematic review of evidence of benefits and harms.
    Edwards SJ; Crawford F; van Velthoven MH; Berardi A; Osei-Assibey G; Bacelar M; Salih F; Wakefield V
    Health Technol Assess; 2016 Dec; 20(94):1-224. PubMed ID: 28051764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Core concepts in pharmacoepidemiology: Measurement of medication exposure in routinely collected healthcare data for causal inference studies in pharmacoepidemiology.
    Thai TN; Winterstein AG
    Pharmacoepidemiol Drug Saf; 2024 Mar; 33(3):e5683. PubMed ID: 37752827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making.
    Etminan M; Gill S; Fitzgerald M; Samii A
    J Clin Pharmacol; 2006 Jan; 46(1):6-9. PubMed ID: 16397278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.